Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations

NCT01347294 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Venous Malformation

Interventions

DRUG: Bleomycin
DRUG: Fibrovein
DRUG: Bleomycin + Fibrovein

Sponsor

Oslo University Hospital